Sustained release indomethacin
Patent 4173626 Issued on November 6, 1979. Estimated Expiration Date: 
December 11, 1998. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
December 11, 1998. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesInventorsAssigneeApplicationNo. 05/968608 filed on 12/11/1978US Classes:424/462, Containing solid synthetic polymers424/456, Gelatin424/497, Containing solid synthetic polymers424/499Contains proteins or derivative or polysaccharides or derivativeExaminersPrimary: Rose, Shep K.Attorney, Agent or FirmInternational ClassesA61K 9/50 (20060101)A61K 31/403 (20060101) A61K 31/405 (20060101) AbstractA sustained release indomethacin pharmaceutical product is provided that utilizes a pellet formulation encapsulated in a hard gelatin capsule. A portion of the pellets is uncoated for immediate and rapid release of indomethacin for elevating the plasma level. The remainder of the pellets are coated with a polymer to sustain the plasma level. The uncoated and coated pellets may be mixed with non-medicated pellets as a capsule filler.Other References
| |
